Thrombosis |

* Inserm, U734; 1UHP, Nancy University;
° Haematology Laboratory, Nancy University, Nancy, France
# Vascular Medicine and
@ Internal Medicine, Nancy University Hospital, Nancy, France:
^ Synapse B.V., CARIM, University of Maastricht, The Netherlands
Inserm, U684; 1UHP
Correspondence: Denis Wahl, Inserm U734, UHP, Faculté de Médecine, 54500 Vandoeuvre-lès-Nancy, France. Phone: international +33.3.83683476. Fax: international +33.3.83683479. E-mail: d.wahl{at}chu-nancy.fr
Interference of antiphospholipid antibodies (aPL) with coagulation was investigated in 40 aPL-patients (24 with thrombosis) using thrombography. Impairment of the activated protein C anticoagulant pathway was partially offset by the genuine anticoagulant effect. The net result, a procoagulant phenotype, was associated with a 7-fold increased risk of thrombosis in aPL-patients.
Key words: antiphospholipid antibody, antiphospholipid syndrome, lupus anticoagulant, APC resistance, thrombin generation.
This article has been cited by other articles:
![]() |
A. Membre, D. Wahl, V. Latger-Cannard, J.-P. Max, P. Lacolley, T. Lecompte, and V. Regnault The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies Haematologica, April 1, 2008; 93(4): 566 - 573. [Abstract] [Full Text] [PDF] |
||||